Market revenue in 2023 | USD 786.6 million |
Market revenue in 2030 | USD 1,604.8 million |
Growth rate | 10.7% (CAGR from 2023 to 2030) |
Largest segment | Outsourcing |
Fastest growing segment | Outsourcing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-House, Outsourcing |
Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.91% in 2023. Horizon Databook has segmented the North America pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the market share in 2023, accounting for nearly 49 % of the total market. This is attributed to the increasing number of pharmaceutical industries within the U.S. and Canada. The presence of a number of major market players in this region is expected to contribute significantly to the market growth.
The expansion of the market in the region can be ascribed to the existence of technologically advanced CROs & CDMOs and an upsurge in the allocation of grants. The increasing prevalence of diverse diseases has led to additional investments in clinical research throughout the projected period.
Furthermore, heightened drug development endeavors, strategic measures like innovation & acquisitions, the presence of pharmaceutical and biotech firms, and a surge in the number of clinical trials in the region are key factors propelling the growth of the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America pharmaceutical sterility testing market , including forecasts for subscribers. This continent databook contains high-level insights into North America pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account